1. Efficacy and toxicity of irinotecan in patients with colorectal cancer;Rothenberg;Semin Oncol.,1998
2. Camptosar (Irinotecan) Label: Center for Drug Evaluation and Research, US Food and Drug Administration http://www.fda.gov/cder/foi/label/2005/020571s024,027,028lbl.pdf
3. Clinical pharmacokinetics and metabolism of irinotecan (CPT-11);Mathijssen;Clin Cancer Res.,2001
4. Bioactivation of the anticancer agent CPT-11 to SN-38 by human hepatic microsomal carboxylesterases and the in vitro assessment of potential drug interactions;Slatter;Drug Metab Dispos.,1997
5. A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini;Ritter;J Biol Chem,1992